The race to treat obesity with powerful new medicines has become one of the defining stories in global healthcare, and Novo ...

Novo Nordisk A/S secures FDA nod for oral Wegovy, expanding obesity treatment options. Click for how oral GLP-1 therapies ...

The pharmaceutical giant's stock has tumbled over the past year and a half, but it could be poised to storm back.

Since early August, the world’s most valuable pharmaceutical stock, Eli Lilly and Company (NYSE: LLY), has put on a stellar ...

Pharmaceutical giants like Lilly and Nordisk are battling for dominance in India’s weight-loss market with price cuts and ...

Johnson & Johnson said on Friday it discontinued a mid-stage study of its ‍experimental drug to treat patients with moderate ...

People covered by Obamacare and Medicaid may see health care costs rise, but for people on Medicare, Biden-era negotiated ...

Hyderabad: Global pharma heavyweights Eli Lilly and Novo Nordisk are racing to lock in market leadership in India’s blooming ...

This pharma company offers you this safety thanks to a broad range of products, but it also offers high growth thanks to its work in one of today's hottest markets. In fact, buying this pharma stock ...

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The U.S. Food and Drug Administration’s ...

The drugs' high prices, along with spotty insurance coverage, have left them out of reach for many Americans. Read more at ...

Wegovy is one of the new wave medications that in recent years have had a huge impact on people looking to l ose weight.